Global Next Generation Sequencing (NGS) Solution Supply, Demand and Key Producers, 2023-2029

Global Next Generation Sequencing (NGS) Solution Supply, Demand and Key Producers, 2023-2029

The global Next Generation Sequencing (NGS) Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Next Generation Sequencing (NGS) Solution demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Next Generation Sequencing (NGS) Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next Generation Sequencing (NGS) Solution that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Next Generation Sequencing (NGS) Solution total market, 2018-2029, (USD Million)

Global Next Generation Sequencing (NGS) Solution total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Next Generation Sequencing (NGS) Solution total market, key domestic companies and share, (USD Million)

Global Next Generation Sequencing (NGS) Solution revenue by player and market share 2018-2023, (USD Million)

Global Next Generation Sequencing (NGS) Solution total market by Type, CAGR, 2018-2029, (USD Million)

Global Next Generation Sequencing (NGS) Solution total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Next Generation Sequencing (NGS) Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies and Pacific Biosciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next Generation Sequencing (NGS) Solution market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Next Generation Sequencing (NGS) Solution Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Next Generation Sequencing (NGS) Solution Market, Segmentation by Type
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing and Resequencing Centrifuges

Global Next Generation Sequencing (NGS) Solution Market, Segmentation by Application
Sporadic Cancer
Inherited Cancer
Companion Diagnostics
Others

Companies Profiled:
Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Myriad Genetics
Foundation Medicine
Oxford Nanopore Technologies
Pacific Biosciences
Paradigm Diagnostics
BGI Group
Caris Life Sciences
Partek
Eurofins Scientific
Qiagen

Key Questions Answered

1. How big is the global Next Generation Sequencing (NGS) Solution market?

2. What is the demand of the global Next Generation Sequencing (NGS) Solution market?

3. What is the year over year growth of the global Next Generation Sequencing (NGS) Solution market?

4. What is the total value of the global Next Generation Sequencing (NGS) Solution market?

5. Who are the major players in the global Next Generation Sequencing (NGS) Solution market?

6. What are the growth factors driving the market demand?